FNY Partners Fund’s Boston Scientific BSX Stock Holding History

FNY Partners Fund’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,000	Closed	-$24K	–	627
2017 Q1	$24K	Buy	+1,000	New	+$24.3K	﹤0.01%	900

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

FNY Partners Fund's BSX Position: Q2 2017 in Review

FNY Partners Fund sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 1,000 shares — an estimated $24K sold.

FNY Partners Fund first reported a position in BSX in Q1 2017 and held it in 1 quarter. The position peaked at $24K in Q1 2017. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

FNY Partners Fund reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 1,000 Boston Scientific shares in Q2 2017, an estimated $24K.
FNY Partners Fund first reported a position in Boston Scientific in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Boston Scientific position peaked at $24K in Q1 2017.
558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.